Egle Therapeutics
Biotechnology Research
Paris, Fr
48 employees
- Employees
- 48
- Contacts
- 2
- Emails
- 2
- Phones
- 1
Egle Therapeutics Overview
- Headquarters
- Paris, Fr
- Website
- www.egle-tx.com
- Industry
- Biotechnology Research
- Employees
- 48
- Founded
- 2020
- Funding
- 10.1M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Egle Therapeutics
Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones.
Egle Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Egle Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Christophe Quéva | Innovation-driven Scientific Leader and Drug Developer |
View
|
|
| Pelletier Benjamin | Research Engineer at Egle Therapeutics, Ph.d. in Immunology from Paris Saclay University |
View
|
|
| Stephen Lau | Biotech C-suite Executive and Board Member - Entrepreneur - Focused on Fundraising & Deal-making - Company Formation | San Francisco Bay Area, United States |
Email
Phone
|
| Michel Detheux | Co-founder, President & CEO Iteos Therapeutics Inc | Watertown, Massachusetts, United States |
Email
|
Employees by Management Level
Individual contributor
3 profiles
Executive
1 profile
Egle Therapeutics Tech Stack
Engineering
2 profiles
Compare Similar Companies to Egle Therapeutics
Cellectis
Biotechnology Research
Innate Pharma
Biotechnology Research
Abivax
Biotechnology
OSE Immunotherapeutics
Biotechnology Research
HiFiBiO Therapeutics
Biotechnology
Candid Therapeutics
Biotechnology Research
Mnemo Therapeutics
Biotechnology Research
PEPTINOV
Biotechnology Research
Acticor Biotech
Biotechnology
PEP-Therapy
Biotechnology Research